List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 21 studies with search of: Abacavir/ Lamivudina/ Zidovudina OR Trizivir[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Active, not recruiting Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: AZT+3TC+ABV (Trizivir);   Drug: Switching to LPV/r monotherapy (Kaletra)
2 Completed A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
Condition: HIV Infection
Interventions: Drug: Trizivir;   Drug: atazanavir;   Drug: Combivir
3 Terminated Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients
Condition: HIV Infections
Interventions: Drug: Trizivir (AZT+3HT+Abacavir) twice daily;   Drug: Viread (300 mg Tenofovir disoproxil fumarate) once daily
4 Completed Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
Condition: HIV Infections
Interventions: Drug: fosamprenavir;   Drug: COMBIVIR;   Drug: ritonavir;   Drug: TRIZIVIR
5 Completed FREE Study: Efficacy and Toxicity of Trizivir
Condition: HIV Infections
Interventions: Drug: Trizivir;   Drug: zidovudine,lamivudine,abacavir
6 Completed Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
Condition: HIV Infections
Interventions: Drug: TRIZIVIR;   Drug: Non-nucleoside reverse transcriptase inhibitor;   Drug: Boosted Protease Inhibitor
7 Completed 2NN & CHARM Long-Term Follow-up Study
Condition: HIV Infections
Interventions: Drug: stavudine;   Drug: lamivudine;   Drug: nevirapine;   Drug: efavirenz;   Drug: trizivir
8 Completed Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Trizivir;   Drug: Lamivudine/Zidovudine;   Drug: Lopinavir/Ritonavir;   Drug: Nevirapine
9 Unknown † Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Efavirenz
10 Completed Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure
Condition: HIV Infection
Interventions: Drug: abacavir/lamivudine/zidovudine;   Drug: tenofovir
11 Completed
Has Results 		Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)
Conditions: HIV;   Tuberculosis
Intervention: Drug: Fixed dose combination zidovudine/lamivudine/abacavir
12 Not yet recruiting Study of Options for Second-Line Effective Combination Therapy (SELECT)
Condition: HIV-1 Infection
Interventions: Drug: Lopinavir/ritonavir;   Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Abacavir/lamivudine/zidovudine;   Drug: Abacavir/lamivudine;   Drug: Lamivudine/zidovudine;   Drug: Abacavir;   Drug: Zidovudine;   Drug: Lamivudine
13 Active, not recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Conditions: Birth Defects;   HIV Infections
Intervention: Drug: Any Antiretroviral Therapy
14 Completed Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine, and Zidovudine;   Drug: Lopinavir/Ritonavir
15 Unknown † Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate
16 Completed Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects
Condition: HIV
Interventions: Drug: Abacavir;   Drug: Darunavir/ritonavir;   Drug: Raltegravir
17 Unknown † A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
Condition: AIDS-Related Kaposi's Sarcoma
Interventions: Drug: abacavir/3TC/zidovudine;   Drug: abacavir /3TC plus ritonavir boosted lopinavir
18 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
19 Completed Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
Conditions: Fracture;   Infection, Human Immunodeficiency Virus
Interventions: Other: No Antiretroviral (ARV) Drug Exposure;   Drug: Any Antiretroviral (ARV) Drug Exposure
20 Active, not recruiting Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection With the Objective to Induce a Strong Specific HIV Immune Response Able to Control Viral Replication Without Highly Active Anti-Retroviral Therapy (HAART)
Condition: HIV
Interventions: Drug: HAART;   Drug: HAART + cyclosporin

Previous Page Studies Shown (1-20) Next Page (21-21)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services